P

Inventor

UTKU NALAN

LU12 patents
⚠️ This page may combine multiple inventors who share the name “UTKU NALAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELLACT PHARMA GMBH

4 patents
US7794715B2Sep 14, 2010

Anti-TIRC7 antibodies in therapy of inflammatory diseases

CELLACT PHARMA GMBH3 citations59
US11892454B2Feb 6, 2024

Method for the diagnosis of etoposide prodrug treatable cancer

CELLACT PHARMA GMBH0 citations48
US10183035B2Jan 22, 2019

Etoposide and prodrugs thereof for use in targeting cancer stem cells

CELLACT PHARMA GMBH0 citations48
US9827261B2Nov 28, 2017

Etoposide and prodrugs thereof for use in targeting cancer stem cells

CELLACT PHARMA GMBH1 citations48

UTKU NALAN

3 patents
US9889147B2Feb 13, 2018

Analogues of etoposide for the treatment of tumours

UTKU NALAN21 citations90
US9399679B2Jul 26, 2016

Therapeutic anti-TIRC7 antibodies for use in immune related and other diseases

UTKU NALAN1 citations48
US8642512B2Feb 4, 2014

Method of detecting early immune activation

UTKU NALAN0 citations48

BRIGHAM & WOMENS HOSPITAL

2 patents
US7931901B2Apr 26, 2011

T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof

BRIGHAM & WOMENS HOSPITAL1 citations48
US7863418B2Jan 4, 2011

T-cell membrane protein (TIRC7) and peptides derived therefrom

BRIGHAM & WOMENS HOSPITAL1 citations48

BRIGHAM & WOMENS HOSPITAL INC

1 patent
US9556271B2Jan 31, 2017

Anti-CEACAM1 recombinant antibodies for cancer therapy

BRIGHAM & WOMENS HOSPITAL INC23 citations90

NEKONAL S A R L

1 patent
US12497451B2Dec 16, 2025

Anti-TIRC7 antigen binding proteins

NEKONAL S A R L0 citations53

PURDUE PHARMA LP

1 patent
US10806745B2Oct 20, 2020

Analogues of etoposide for the treatment of tumours

PURDUE PHARMA LP0 citations50